DAFTAR PUSTAKA
1. Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet[Internet]. 2009[cited 2012 Aug 28]; 46:145–58. Available from : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643051/
2. Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with apathogenic mtDNA mutation. Am J Hum Genet [Internet]. 1995 [cited 2012 Aug 13];57(1):77–
86. Available from: Poulton J, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. American journal of human genetics[Internet]. 1996 [cited 2012 Aug 13] ;59(2):481. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914749/pdf/ajhg00021-0208 .pdf
5. Johns DR, Colby KA, editors. Treatment of Leber's hereditary optic neuropathy: theory to practice. Seminars in Ophthalmology; 2002: Informa UK Ltd UK.
6. Nishioka T, Tasaki M, Soemantri A, Dyat M, Susanto J, Tamam M, et al. Leber's hereditary optic neuropathy with 14484 mutation in Central Java, Indonesia. Journal of human genetics[Internet]. 2003 [cited 2012 Aug 2013];
48(7):385-9. Available from:
http://www.springerlink.com/index/64JQE9F1JHWKX79Q.pdf
7. Nikoskelainen E, Marttila R, Huoponen K, Juvonen V, Lamminen T, Sonninen P, et al. Leber's" plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. Journal of Neurology, Neurosurgery & Psychiatry[Internet]. 1995[cited 2012 Aug 13]; 59(2):160-4. Available from : http://jnnp.bmj.com/content/59/2/160.full.pdf
8. Savini G, Barboni P, Valentino ML, Montagna P, Cortelli P, De Negri AM, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Ophthalmology[Internet]. 2005[Cited 2012 Aug 13]; 112(1):127-31.
Available from:
http://www.sciencedirect.com/science/article/pii/S0161642004016574
9. Man PY, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet. 2002;39:162–9.
11. Yanagisawa M, Kato S, Kobayashi M, Watanabe M, Ochiai M. Relationship between vision-related quality of life and different types of existing visual fields in Japanese patients. International Ophthalmology. 2012:1-7.
12. Joan Stelmack O. QUALITY OF LIFE ASSESSMENT AND RESEARCH ON HEALTH CARE OUTCOMES. Journal Article, Available from: webpages.charter.net
13. Kirkman MA, Korsten A, Leonhardt M, Dimitriadis K, Ireneaus F, Klopstock T, et al. Quality of life in patients with leber hereditary optic neuropathy. Investigative ophthalmology & visual science[Internet]. 2009[cited 2012 Aug
13]; 50(7):3112-5. Available from:
http://www.iovs.org/content/50/7/3112.full
14. Suzukamo Y, Oshika T, Yuzawa M, Tokuda Y, Tomidokoro A, Oki K, et al. Psychometric properties of the 25-item national eye institute visual function questionnaire (NEI VFQ-25), japanese version. Health and quality of life outcomes. 2005;3(1):65. Available from: http://www.biomedcentral.com/1477-7525/3/65
15. Deramo VA, Cox TA, Syed AB, Lee PP, Fekrat S. Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology. 2003;121(9):1297.
16. McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008;115(6):941-8.
17. Riordan-Eva P, Whitcher J. Vaughan & Asbury's general ophthalmology: Wiley Online Library; 2008.
19. Hayreh SS: Anatomy and physiology of the optic nerve head. Trans Am Acad Ophthalmol Otolaryngol. 1974. 78:240
10.
http://webeye.ophth.uiowa.edu/component/content/article/118-aionpart2?start =1
21. Kujoth G, Hiona A, Pugh T, Someya S, Panzer K, Wohlgemuth S, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science[Internet]. 2005[Cited 2012 Dec] ;309(5733):481. Available
f r o m :
http://newburyparkhighschool.net/lockwood/IBBio/HANDOUTS/ARTICLE-mtDNA_Aging.pdf
22. http://www.sciencedirect.com/science/article/pii/B9780702029837000437 23. Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De
neuropathy. Brain[Internet]. 2009[cited 2012 Dec 7];132(9):2317-26. Available from: http://brain.oxfordjournals.org/content/132/9/2317.long 24. Man PYW, Turnbull D, Chinnery P. Leber hereditary optic neuropathy.
Journal of medical genetics[Internet]. 2002 [Last revised April 19, 2012, cited 2012 Aug 13];39(3):162-9. Available from: http://jmg.bmj.com/content/39/3/162.full
25. Newman NJ, Biousse V, Newman SA, Bhatti MT, Hamilton SR, Farris BK, et al. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial. American journal of ophthalmology. 2006;141(6):1061-7. e1. Available from: http://www.ajo.com/article/s0002-9394(06)00018-3/abstract
26. Johns DR, Neufeld M. Pitfalls in the molecular genetic diagnosis of Leber hereditary optic neuropathy (LHON). American journal of human genetics. 1993;53(4):916.
27. Chalmers R, Schapira A. Clinical, biochemical and molecular genetic features of Leber's hereditary optic neuropathy. Biochimica et biophysica acta. 1999;1410(2):147.
28. Singh G, Lott MT, Wallace DC. A mitochondrial DNA mutation as a cause of Leber's hereditary optic neuropathy. New England Journal of Medicine. 1989;320(20):1300-5.
29. Brown MD, Voljavec AS, Lott M, Torroni A, Yang CC, Wallace DC. Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy. Genetics. 1992;130(1):163-73.
30. Vilkki J, Savontaus M, Nikoskelainen E. Genetic heterogeneity in Leber hereditary optic neuroretinopathy revealed by mitochondrial DNA polymorphism. American journal of human genetics. 1989;45(2):206.
31. Greaves LC, Reeve AK, Taylor RW, Turnbull DM. Mitochondrial DNA and disease. The Journal of pathology[Internet]. 2012[cited 2012 Dec]; 226: 275.
Available from :
http://www.muskelkrank.ch/downloads/forschung/Turnbull.%20Review.pdf 32. Mariotti C, Tiranti V, Carrara F, Dallapiccola B, DiDonato S, Zeviani M.
Defective respiratory capacity and mitochondrial protein synthesis in transformant cybrids harboring the tRNA (Leu (UUR)) mutation associated with maternally inherited myopathy and cardiomyopathy. Journal of Clinical Investigation[Internet]. 1994[cited 2012 Dec];93(3):1102. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC294050/pdf/jcinvest00032-01 92.pdf
33. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nature Reviews Genetics. 2005;6(5):389-402.
34. Campbell. Biologi,Edisi kelima Jilid I,164-165,197. Jakarta: Erlangga; 2002. 35. Murray, Robert K, Granner Daryl K, Rodwell Victor W. Biokimia Harper
Ed.25, Jakarta:Penerbit Buku Kedokteran EGC;2006.
Biology[Internet].2013[cited january 2013]. 45(1):34-40. Available from: http://www.sciencedirect.com/science/article/pii/S1357272512002877
37. Danielson SR, Wong A, Carelli V, Martinuzzi A, Schapira AHV, Cortopassi GA. Cells bearing mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-Induced apoptosis. Journal of Biological Chemistry[Internet]. 2002[Cited 2013 Jan 16];277(8):5810-5. Available from: http://www.jbc.org/content/277/8/5810.long
38. Venna N. Mitochondrial neurological diseases: a clinician’s perspective. Neurology India. 2004;52(3):305.
39. Wallace DC. Mitochondrial defects in cardiomyopathy and neuromuscular disease. American heart journal. 2000;139(2):s70-s85.
40. Nikoskelainen E, Marttila R, Huoponen K, Juvonen V, Lamminen T, Sonninen P, et al. Leber's" plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. Journal of Neurology, Neurosurgery & Psychiatry[Internet]. 1995[cited 2012 Aug];59(2):160-4. Available from: http://jnnp.bmj.com/content/59/2/160.full.pdf
41. Quiros P, Torres R, Salomao S, Berezovsky A, Carelli V, Sherman J, et al. Colour vision defects in asymptomatic carriers of the Leber’s hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study. British journal of ophthalmology[Internet]. 2006[cited 2012 Sep 14];90(2):150-3. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860163/
42. Yen MY, Wang AG, Wei YH. Leber's hereditary optic neuropathy: a multifactorial disease. Progress in retinal and eye research. 2006;25(4):381-96.
43. WHOQOL: Measuring Quality of Life. 1997. Available from: URL: http//www.int/mental_health/media/68.pdf
44. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Annals of internal medicine. 1993;118(8):622.
45. Halim MS. QUALITY OF LIFE AND BREAST CANCER: FROM RESEARCH TO ‘FUTURE’ISSUES. Jurnal psikologi. 2004;12:1-11. Available from: http://isjd.pdii.lipi.go.id/admin/jurnal/13104112.pdf
46. Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Archives of Ophthalmology[Internet]. 1998[cited 2012 Feb
6];116(2):227. Available from:
http://archopht.ama-assn.org/cgi/reprint/116/2/227.pdf
47. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item national eye institute visual function questionnaire. Archives of Ophthalmology[Internet]. 2001[cited 2012 Feb
6];119(7):1050. Available from:
48. Rossi GC, Milano G, Tinelli C: The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J Glaucoma 2003, 12:213-220
49. Nordmann JP, Viala M, Sullivan K, Arnould B, Berdeaux G: Psychometric Validation of the National Eye Institute Visual Function Questionnaire – 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics 2004; 22:197-206.
50. Broman AT, Munoz B, West SK, Rodriguez J, Sanchez R, Snyder R, Klein R: Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER. Invest Ophthalmol Vis Sci 2001; 42:606-613
51. Franke GH, Esser J, Reimer J, Maehner N: Vision targeted quality of life under different degrees of visual impairment. Revista Portuguesa de Psicossomática 2002; 4:39-49.
52. Suzukamo Y, Oshika T, Yuzawa M, Tokuda Y, Tomidokoro A, Oki K, et al. Psychometric properties of the 25-item national eye institute visual function questionnaire (NEI VFQ-25), japanese version. Health and quality of life outcomes. 2005;3(1):65.
53. COMS Quality of Life Study Group: Quality of life assessment in the collaborative ocular melanoma study: design and methods. COMS-QOLS Report No. 1. Ophthalmic Epidemiol 1999;6:5-17.
54. Cole SR, Beck RW, Moke PS, Gal RL, Long DT. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci 2000; 41:1017-1021.
55. Miskala PH, Bressler NM, Meinert CL. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Arch Ophthalmol 2004; 122:758-766. 56. O’Conner M, TenHove MW. Health-Related Quality of Life for person
affected by Leber’s Hereditary Optic Neuropathy. NANOS 2000: Poster Presentations. Available from :
http://content.lib.utah.edu/cdm/ref/collection/ehsl-nam/id/3866
57. Ziaei H, Katibeh M, Sabbaghi M, Yaseri M, Eskandari A. Vision Related Quality of Life in Myopia; Photorefractive Keratectomy versus Nonsurgical Optical Correction. Journal of ophthalmic & vision research. 2012;7(3):219.
58. Klein R, Moss SE, Klein BK, Gutierrez P, Mangione CM. The NEI-VFQ-25 in People With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol. 2001;119(5):733-740. doi:10.1001/archopht.119.5.733. Available from : http://archopht.jamanetwork.com/article.aspx?articleid=266360
60. Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, et al. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Investigative ophthalmology & visual science. 2011;52(6):3354-9. Available from : http://www.iovs.org/content/52/6/3354.long
61. Wu S-Y, Hennis A, Nemesure B, Leske MC. Impact of glaucoma, lens opacities, and cataract surgery on visual functioning and related quality of life: the Barbados Eye Studies. Investigative ophthalmology & visual science. 2008;49(4):1333-8.
Available from : http://www.iovs.org/content/49/4/1333.long
62. Jampel HD, Schwartz A, Pollack I, Abrams D, Weiss H, Miller R. Glaucoma patients' assessment of their visual function and quality of life. Journal of glaucoma. 2002;11(2):154-63.
63. Walker JG, Anstey KJ, Lord SR. Psychological distress and visual functioning in relation to vision-related disability in older individuals with cataracts. British Journal of Health Psychology. 2006;11:303–317.
64. Matza LS, Rousculp MD, Malley K, Boye KS, Oglesby A. The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy. Health Qual Life Outcomes. 2008;6(1):95. Available from : http://www.hqlo.com/content/6/1/95
65. Horowitz A. The prevalence and consequences of vision impairment in later life. Topics in Geriatric Rehabilitation. 2004;20:185–195.
66. Rowan HH. Visual problems and falls. Age and ageing. 2001;30(S4):13–18. 67. Sugawara T, Hagiwara A, Hiramatsu A, Ogata K, Mitamura Y, Yamamoto S.
Relationship between peripheral visual field loss and vision-related quality of life in patients with retinitis pigmentosa. Eye. 2009;24(4):535-9.
68. Van Senus AHC, Leber’s Disease in Netherland. Doc Ophtalmol .1963;17:1-163
69. Rothe NK, Sjolie AK, Jensen H, Borch-Johnsen K and Rosenberg T. The prevalence and incidence of visual impairment in people of age 20-59 years in industrialized countries: a review. 2003. Ophthalmic Epidemiology. 10 (4): 279-291
70. Boerner K and Cimarolli VR. Optimizing rehabilitation for adults with visual impairment: attention to life goals and their links to well-being. 2005. Clinical Rehabilitation.19 (7): 790-798.
LAMPIRAN
2. Lembar Informed Consent
